Gene therapy for people with hepatocellular carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Gene Therapy for People With Hepatocellular Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440641/all/Gene_therapy_for_people_with_hepatocellular_carcinoma.
Gene therapy for people with hepatocellular carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440641/all/Gene_therapy_for_people_with_hepatocellular_carcinoma. Accessed March 19, 2025.
Gene therapy for people with hepatocellular carcinoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440641/all/Gene_therapy_for_people_with_hepatocellular_carcinoma
Gene Therapy for People With Hepatocellular Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440641/all/Gene_therapy_for_people_with_hepatocellular_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gene therapy for people with hepatocellular carcinoma
ID - 440641
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440641/all/Gene_therapy_for_people_with_hepatocellular_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -